Norwegian research Rituximab in ME/Chronic Fatigue Syndrome, PloS ONE, Fluge and Mella

Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study.